nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0941	0.223	CbGbCtD
Midazolam—CYP3A7—Docetaxel—head and neck cancer	0.0941	0.223	CbGbCtD
Midazolam—CYP3A5—Docetaxel—head and neck cancer	0.0706	0.167	CbGbCtD
Midazolam—ABCB1—Vinblastine—head and neck cancer	0.0557	0.132	CbGbCtD
Midazolam—ABCB1—Docetaxel—head and neck cancer	0.0459	0.109	CbGbCtD
Midazolam—CYP3A4—Vinblastine—head and neck cancer	0.0334	0.0792	CbGbCtD
Midazolam—CYP3A4—Docetaxel—head and neck cancer	0.0275	0.0653	CbGbCtD
Midazolam—Skin necrosis—Hydroxyurea—head and neck cancer	0.016	0.0525	CcSEcCtD
Midazolam—Application site pain—Fluorouracil—head and neck cancer	0.00917	0.03	CcSEcCtD
Midazolam—Slurred speech—Fluorouracil—head and neck cancer	0.00902	0.0295	CcSEcCtD
Midazolam—Nystagmus—Vinblastine—head and neck cancer	0.00861	0.0282	CcSEcCtD
Midazolam—Digestion impaired—Hydroxyurea—head and neck cancer	0.00839	0.0274	CcSEcCtD
Midazolam—Clonazepam—NAT2—head and neck cancer	0.00733	1	CrCbGaD
Midazolam—Local reaction—Fluorouracil—head and neck cancer	0.00729	0.0238	CcSEcCtD
Midazolam—Tenderness—Hydroxyurea—head and neck cancer	0.00643	0.021	CcSEcCtD
Midazolam—Nystagmus—Fluorouracil—head and neck cancer	0.00565	0.0185	CcSEcCtD
Midazolam—Skin exfoliation—Hydroxyurea—head and neck cancer	0.00535	0.0175	CcSEcCtD
Midazolam—Phlebitis—Vinblastine—head and neck cancer	0.00518	0.0169	CcSEcCtD
Midazolam—Tenderness—Fluorouracil—head and neck cancer	0.00463	0.0151	CcSEcCtD
Midazolam—Disorientation—Hydroxyurea—head and neck cancer	0.00455	0.0149	CcSEcCtD
Midazolam—Redness—Docetaxel—head and neck cancer	0.00431	0.0141	CcSEcCtD
Midazolam—Dysarthria—Fluorouracil—head and neck cancer	0.00427	0.014	CcSEcCtD
Midazolam—Rhinorrhoea—Docetaxel—head and neck cancer	0.0036	0.0118	CcSEcCtD
Midazolam—Euphoric mood—Fluorouracil—head and neck cancer	0.00347	0.0113	CcSEcCtD
Midazolam—Depression—Vinblastine—head and neck cancer	0.00343	0.0112	CcSEcCtD
Midazolam—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00338	0.0111	CcSEcCtD
Midazolam—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00337	0.011	CcSEcCtD
Midazolam—Swelling—Fluorouracil—head and neck cancer	0.00332	0.0109	CcSEcCtD
Midazolam—Disorientation—Fluorouracil—head and neck cancer	0.00327	0.0107	CcSEcCtD
Midazolam—Drowsiness—Hydroxyurea—head and neck cancer	0.00314	0.0103	CcSEcCtD
Midazolam—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00307	0.0101	CcSEcCtD
Midazolam—UGT1A4—mouth—head and neck cancer	0.00301	0.0913	CbGeAlD
Midazolam—Cardiac failure—Fluorouracil—head and neck cancer	0.003	0.00982	CcSEcCtD
Midazolam—Lethargy—Fluorouracil—head and neck cancer	0.00299	0.00978	CcSEcCtD
Midazolam—Respiratory failure—Docetaxel—head and neck cancer	0.00297	0.00971	CcSEcCtD
Midazolam—Osteoarthritis—Fluorouracil—head and neck cancer	0.00293	0.00959	CcSEcCtD
Midazolam—Hallucination—Hydroxyurea—head and neck cancer	0.0028	0.00917	CcSEcCtD
Midazolam—Irritability—Fluorouracil—head and neck cancer	0.0028	0.00915	CcSEcCtD
Midazolam—Cardiac arrest—Fluorouracil—head and neck cancer	0.00279	0.00911	CcSEcCtD
Midazolam—Skin exfoliation—Docetaxel—head and neck cancer	0.00278	0.0091	CcSEcCtD
Midazolam—Ataxia—Fluorouracil—head and neck cancer	0.00275	0.00901	CcSEcCtD
Midazolam—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00262	0.00857	CcSEcCtD
Midazolam—Lightheadedness—Docetaxel—head and neck cancer	0.00261	0.00853	CcSEcCtD
Midazolam—Muscular weakness—Fluorouracil—head and neck cancer	0.00258	0.00845	CcSEcCtD
Midazolam—Chills—Hydroxyurea—head and neck cancer	0.00253	0.00827	CcSEcCtD
Midazolam—Phlebitis—Docetaxel—head and neck cancer	0.00245	0.00803	CcSEcCtD
Midazolam—Erythema—Hydroxyurea—head and neck cancer	0.00245	0.00802	CcSEcCtD
Midazolam—Thrombophlebitis—Docetaxel—head and neck cancer	0.00244	0.00799	CcSEcCtD
Midazolam—Vertigo—Vinblastine—head and neck cancer	0.00241	0.0079	CcSEcCtD
Midazolam—Swelling—Docetaxel—head and neck cancer	0.0024	0.00784	CcSEcCtD
Midazolam—Visual disturbance—Docetaxel—head and neck cancer	0.00223	0.0073	CcSEcCtD
Midazolam—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00221	0.00724	CcSEcCtD
Midazolam—Cardiac failure—Docetaxel—head and neck cancer	0.00217	0.00709	CcSEcCtD
Midazolam—Lethargy—Docetaxel—head and neck cancer	0.00216	0.00706	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00207	0.00678	CcSEcCtD
Midazolam—Ataxia—Docetaxel—head and neck cancer	0.00199	0.00651	CcSEcCtD
Midazolam—Paraesthesia—Vinblastine—head and neck cancer	0.00197	0.00644	CcSEcCtD
Midazolam—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00196	0.00642	CcSEcCtD
Midazolam—Skin disorder—Hydroxyurea—head and neck cancer	0.00194	0.00636	CcSEcCtD
Midazolam—Nasopharyngitis—Docetaxel—head and neck cancer	0.00189	0.00619	CcSEcCtD
Midazolam—Constipation—Vinblastine—head and neck cancer	0.00188	0.00614	CcSEcCtD
Midazolam—Pain—Vinblastine—head and neck cancer	0.00188	0.00614	CcSEcCtD
Midazolam—Feeling abnormal—Vinblastine—head and neck cancer	0.00181	0.00591	CcSEcCtD
Midazolam—Bronchospasm—Docetaxel—head and neck cancer	0.0018	0.00588	CcSEcCtD
Midazolam—Dyspnoea—Hydroxyurea—head and neck cancer	0.00178	0.00584	CcSEcCtD
Midazolam—Somnolence—Hydroxyurea—head and neck cancer	0.00178	0.00582	CcSEcCtD
Midazolam—Erythema—Fluorouracil—head and neck cancer	0.00176	0.00577	CcSEcCtD
Midazolam—Dyspepsia—Hydroxyurea—head and neck cancer	0.00176	0.00576	CcSEcCtD
Midazolam—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00173	0.00565	CcSEcCtD
Midazolam—Fatigue—Hydroxyurea—head and neck cancer	0.00172	0.00564	CcSEcCtD
Midazolam—Pain—Hydroxyurea—head and neck cancer	0.00171	0.0056	CcSEcCtD
Midazolam—Constipation—Hydroxyurea—head and neck cancer	0.00171	0.0056	CcSEcCtD
Midazolam—GABRP—mouth—head and neck cancer	0.00167	0.0507	CbGeAlD
Midazolam—Vision blurred—Fluorouracil—head and neck cancer	0.00166	0.00544	CcSEcCtD
Midazolam—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00165	0.00539	CcSEcCtD
Midazolam—GABRE—hair follicle—head and neck cancer	0.00163	0.0494	CbGeAlD
Midazolam—Hypersensitivity—Vinblastine—head and neck cancer	0.00162	0.00529	CcSEcCtD
Midazolam—Neuropathy peripheral—Docetaxel—head and neck cancer	0.0016	0.00523	CcSEcCtD
Midazolam—Asthenia—Vinblastine—head and neck cancer	0.00157	0.00515	CcSEcCtD
Midazolam—CYP4B1—trachea—head and neck cancer	0.00153	0.0464	CbGeAlD
Midazolam—GABRA3—neck—head and neck cancer	0.00148	0.0448	CbGeAlD
Midazolam—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00147	0.00482	CcSEcCtD
Midazolam—Confusional state—Fluorouracil—head and neck cancer	0.00145	0.00475	CcSEcCtD
Midazolam—Dizziness—Vinblastine—head and neck cancer	0.00145	0.00475	CcSEcCtD
Midazolam—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00144	0.00471	CcSEcCtD
Midazolam—Connective tissue disorder—Docetaxel—head and neck cancer	0.00144	0.0047	CcSEcCtD
Midazolam—Asthenia—Hydroxyurea—head and neck cancer	0.00144	0.0047	CcSEcCtD
Midazolam—Nervous system disorder—Fluorouracil—head and neck cancer	0.00141	0.00462	CcSEcCtD
Midazolam—Visual impairment—Docetaxel—head and neck cancer	0.00141	0.00461	CcSEcCtD
Midazolam—Tachycardia—Fluorouracil—head and neck cancer	0.00141	0.0046	CcSEcCtD
Midazolam—Vomiting—Vinblastine—head and neck cancer	0.00139	0.00456	CcSEcCtD
Midazolam—Headache—Vinblastine—head and neck cancer	0.00137	0.0045	CcSEcCtD
Midazolam—Eye disorder—Docetaxel—head and neck cancer	0.00137	0.00447	CcSEcCtD
Midazolam—Cardiac disorder—Docetaxel—head and neck cancer	0.00136	0.00444	CcSEcCtD
Midazolam—Hypotension—Fluorouracil—head and neck cancer	0.00135	0.0044	CcSEcCtD
Midazolam—Dizziness—Hydroxyurea—head and neck cancer	0.00132	0.00433	CcSEcCtD
Midazolam—Immune system disorder—Docetaxel—head and neck cancer	0.00132	0.00432	CcSEcCtD
Midazolam—Mediastinal disorder—Docetaxel—head and neck cancer	0.00132	0.00431	CcSEcCtD
Midazolam—Chills—Docetaxel—head and neck cancer	0.00131	0.00429	CcSEcCtD
Midazolam—Nausea—Vinblastine—head and neck cancer	0.0013	0.00426	CcSEcCtD
Midazolam—Paraesthesia—Fluorouracil—head and neck cancer	0.00129	0.00423	CcSEcCtD
Midazolam—Dyspnoea—Fluorouracil—head and neck cancer	0.00128	0.0042	CcSEcCtD
Midazolam—Mental disorder—Docetaxel—head and neck cancer	0.00128	0.00419	CcSEcCtD
Midazolam—Somnolence—Fluorouracil—head and neck cancer	0.00128	0.00419	CcSEcCtD
Midazolam—Erythema—Docetaxel—head and neck cancer	0.00127	0.00417	CcSEcCtD
Midazolam—Vomiting—Hydroxyurea—head and neck cancer	0.00127	0.00416	CcSEcCtD
Midazolam—Dyspepsia—Fluorouracil—head and neck cancer	0.00127	0.00415	CcSEcCtD
Midazolam—Rash—Hydroxyurea—head and neck cancer	0.00126	0.00413	CcSEcCtD
Midazolam—Dermatitis—Hydroxyurea—head and neck cancer	0.00126	0.00412	CcSEcCtD
Midazolam—Headache—Hydroxyurea—head and neck cancer	0.00125	0.0041	CcSEcCtD
Midazolam—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00124	0.00407	CcSEcCtD
Midazolam—Pain—Fluorouracil—head and neck cancer	0.00123	0.00403	CcSEcCtD
Midazolam—CYP4B1—thyroid gland—head and neck cancer	0.00121	0.0367	CbGeAlD
Midazolam—Nausea—Hydroxyurea—head and neck cancer	0.00119	0.00389	CcSEcCtD
Midazolam—Feeling abnormal—Fluorouracil—head and neck cancer	0.00119	0.00388	CcSEcCtD
Midazolam—Urticaria—Fluorouracil—head and neck cancer	0.00114	0.00374	CcSEcCtD
Midazolam—Syncope—Docetaxel—head and neck cancer	0.00114	0.00374	CcSEcCtD
Midazolam—Cough—Docetaxel—head and neck cancer	0.00111	0.00364	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00108	0.00352	CcSEcCtD
Midazolam—CYP4B1—head—head and neck cancer	0.00107	0.0325	CbGeAlD
Midazolam—Hypersensitivity—Fluorouracil—head and neck cancer	0.00106	0.00347	CcSEcCtD
Midazolam—Dry mouth—Docetaxel—head and neck cancer	0.00106	0.00347	CcSEcCtD
Midazolam—Confusional state—Docetaxel—head and neck cancer	0.00105	0.00343	CcSEcCtD
Midazolam—Anaphylactic shock—Docetaxel—head and neck cancer	0.00104	0.0034	CcSEcCtD
Midazolam—Shock—Docetaxel—head and neck cancer	0.00102	0.00335	CcSEcCtD
Midazolam—Nervous system disorder—Docetaxel—head and neck cancer	0.00102	0.00333	CcSEcCtD
Midazolam—Pruritus—Fluorouracil—head and neck cancer	0.00102	0.00333	CcSEcCtD
Midazolam—Tachycardia—Docetaxel—head and neck cancer	0.00101	0.00332	CcSEcCtD
Midazolam—Skin disorder—Docetaxel—head and neck cancer	0.00101	0.0033	CcSEcCtD
Midazolam—GABRQ—head—head and neck cancer	0.000996	0.0302	CbGeAlD
Midazolam—GABRR3—head—head and neck cancer	0.000996	0.0302	CbGeAlD
Midazolam—Hypotension—Docetaxel—head and neck cancer	0.000971	0.00318	CcSEcCtD
Midazolam—Dizziness—Fluorouracil—head and neck cancer	0.000952	0.00312	CcSEcCtD
Midazolam—Paraesthesia—Docetaxel—head and neck cancer	0.000933	0.00305	CcSEcCtD
Midazolam—Dyspnoea—Docetaxel—head and neck cancer	0.000926	0.00303	CcSEcCtD
Midazolam—Somnolence—Docetaxel—head and neck cancer	0.000924	0.00302	CcSEcCtD
Midazolam—Vomiting—Fluorouracil—head and neck cancer	0.000915	0.003	CcSEcCtD
Midazolam—Dyspepsia—Docetaxel—head and neck cancer	0.000915	0.00299	CcSEcCtD
Midazolam—Rash—Fluorouracil—head and neck cancer	0.000908	0.00297	CcSEcCtD
Midazolam—Dermatitis—Fluorouracil—head and neck cancer	0.000907	0.00297	CcSEcCtD
Midazolam—Headache—Fluorouracil—head and neck cancer	0.000902	0.00295	CcSEcCtD
Midazolam—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000897	0.00294	CcSEcCtD
Midazolam—Fatigue—Docetaxel—head and neck cancer	0.000896	0.00293	CcSEcCtD
Midazolam—Constipation—Docetaxel—head and neck cancer	0.000889	0.00291	CcSEcCtD
Midazolam—Pain—Docetaxel—head and neck cancer	0.000889	0.00291	CcSEcCtD
Midazolam—GABRG3—head—head and neck cancer	0.000872	0.0265	CbGeAlD
Midazolam—GABRR2—head—head and neck cancer	0.000864	0.0262	CbGeAlD
Midazolam—GABRP—trachea—head and neck cancer	0.000861	0.0261	CbGeAlD
Midazolam—Feeling abnormal—Docetaxel—head and neck cancer	0.000856	0.0028	CcSEcCtD
Midazolam—Nausea—Fluorouracil—head and neck cancer	0.000855	0.0028	CcSEcCtD
Midazolam—GABRR1—head—head and neck cancer	0.000831	0.0252	CbGeAlD
Midazolam—Hypersensitivity—Docetaxel—head and neck cancer	0.000766	0.00251	CcSEcCtD
Midazolam—CYP4B1—lymph node—head and neck cancer	0.000751	0.0228	CbGeAlD
Midazolam—Asthenia—Docetaxel—head and neck cancer	0.000746	0.00244	CcSEcCtD
Midazolam—Pruritus—Docetaxel—head and neck cancer	0.000735	0.00241	CcSEcCtD
Midazolam—GABRD—head—head and neck cancer	0.000722	0.0219	CbGeAlD
Midazolam—GABRA3—thyroid gland—head and neck cancer	0.000704	0.0213	CbGeAlD
Midazolam—GABRG1—head—head and neck cancer	0.000695	0.0211	CbGeAlD
Midazolam—GABRA6—head—head and neck cancer	0.000691	0.021	CbGeAlD
Midazolam—Dizziness—Docetaxel—head and neck cancer	0.000687	0.00225	CcSEcCtD
Midazolam—GABRB1—head—head and neck cancer	0.000674	0.0205	CbGeAlD
Midazolam—GABRA5—head—head and neck cancer	0.000671	0.0203	CbGeAlD
Midazolam—GABRB3—connective tissue—head and neck cancer	0.000663	0.0201	CbGeAlD
Midazolam—Vomiting—Docetaxel—head and neck cancer	0.000661	0.00216	CcSEcCtD
Midazolam—GABRE—trachea—head and neck cancer	0.000657	0.0199	CbGeAlD
Midazolam—Rash—Docetaxel—head and neck cancer	0.000655	0.00214	CcSEcCtD
Midazolam—Dermatitis—Docetaxel—head and neck cancer	0.000655	0.00214	CcSEcCtD
Midazolam—Headache—Docetaxel—head and neck cancer	0.000651	0.00213	CcSEcCtD
Midazolam—GABRA3—head—head and neck cancer	0.000624	0.0189	CbGeAlD
Midazolam—Nausea—Docetaxel—head and neck cancer	0.000617	0.00202	CcSEcCtD
Midazolam—GABRA4—head—head and neck cancer	0.000608	0.0185	CbGeAlD
Midazolam—GABRR2—lymph node—head and neck cancer	0.000605	0.0183	CbGeAlD
Midazolam—GABRP—head—head and neck cancer	0.000604	0.0183	CbGeAlD
Midazolam—GABRE—thyroid gland—head and neck cancer	0.00052	0.0158	CbGeAlD
Midazolam—GABRG2—head—head and neck cancer	0.000509	0.0154	CbGeAlD
Midazolam—GABRB2—head—head and neck cancer	0.000509	0.0154	CbGeAlD
Midazolam—GABRA2—head—head and neck cancer	0.000465	0.0141	CbGeAlD
Midazolam—GABRE—head—head and neck cancer	0.000461	0.014	CbGeAlD
Midazolam—GABRA1—head—head and neck cancer	0.000449	0.0136	CbGeAlD
Midazolam—GABRB3—thyroid gland—head and neck cancer	0.000441	0.0134	CbGeAlD
Midazolam—SLC22A1—head—head and neck cancer	0.000439	0.0133	CbGeAlD
Midazolam—CYP3A7—Biological oxidations—GSTM1—head and neck cancer	0.000418	0.0018	CbGpPWpGaD
Midazolam—CYP3A7—Metapathway biotransformation—GSTM1—head and neck cancer	0.000412	0.00177	CbGpPWpGaD
Midazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000405	0.00174	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—YAP1—head and neck cancer	0.000398	0.00171	CbGpPWpGaD
Midazolam—CYP3A7—Biological oxidations—CYP1A1—head and neck cancer	0.000396	0.0017	CbGpPWpGaD
Midazolam—GABRB3—head—head and neck cancer	0.000391	0.0119	CbGeAlD
Midazolam—CYP3A7—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000391	0.00168	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000388	0.00167	CbGpPWpGaD
Midazolam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000386	0.00166	CbGpPWpGaD
Midazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000386	0.00166	CbGpPWpGaD
Midazolam—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000382	0.00164	CbGpPWpGaD
Midazolam—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000367	0.00158	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000364	0.00156	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000353	0.00152	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—UROD—head and neck cancer	0.000348	0.0015	CbGpPWpGaD
Midazolam—CYP2B6—lymphoid tissue—head and neck cancer	0.000329	0.00997	CbGeAlD
Midazolam—GABRA2—lymph node—head and neck cancer	0.000326	0.00988	CbGeAlD
Midazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000325	0.0014	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—UROD—head and neck cancer	0.000324	0.00139	CbGpPWpGaD
Midazolam—GABRE—lymph node—head and neck cancer	0.000323	0.00979	CbGeAlD
Midazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000318	0.00137	CbGpPWpGaD
Midazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000314	0.00135	CbGpPWpGaD
Midazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.00031	0.00133	CbGpPWpGaD
Midazolam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.00031	0.00133	CbGpPWpGaD
Midazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000309	0.00133	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	0.000309	0.00133	CbGpPWpGaD
Midazolam—CYP2E1—lymphoid tissue—head and neck cancer	0.000309	0.00936	CbGeAlD
Midazolam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000305	0.00131	CbGpPWpGaD
Midazolam—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000305	0.00131	CbGpPWpGaD
Midazolam—GABRR1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000305	0.00131	CbGpPWpGaD
Midazolam—CYP2E1—Biological oxidations—GSTM1—head and neck cancer	0.000303	0.0013	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	0.000302	0.0013	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—NAT2—head and neck cancer	0.0003	0.00129	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000299	0.00129	CbGpPWpGaD
Midazolam—CYP2E1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000299	0.00128	CbGpPWpGaD
Midazolam—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	0.000298	0.00128	CbGpPWpGaD
Midazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000297	0.00127	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.000294	0.00126	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	0.000293	0.00126	CbGpPWpGaD
Midazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000293	0.00126	CbGpPWpGaD
Midazolam—GABRQ—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000291	0.00125	CbGpPWpGaD
Midazolam—GABRR2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000291	0.00125	CbGpPWpGaD
Midazolam—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000289	0.00124	CbGpPWpGaD
Midazolam—CYP2E1—Biological oxidations—CYP1A1—head and neck cancer	0.000287	0.00123	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	0.000286	0.00123	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000284	0.00122	CbGpPWpGaD
Midazolam—CYP2E1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000283	0.00122	CbGpPWpGaD
Midazolam—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000282	0.00121	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.00028	0.00121	CbGpPWpGaD
Midazolam—CYP2E1—thyroid gland—head and neck cancer	0.00028	0.0085	CbGeAlD
Midazolam—GABRB3—BDNF signaling pathway—STAT3—head and neck cancer	0.000268	0.00115	CbGpPWpGaD
Midazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000268	0.00115	CbGpPWpGaD
Midazolam—CYP2B6—head—head and neck cancer	0.000265	0.00804	CbGeAlD
Midazolam—UGT1A4—Metabolism—DPYD—head and neck cancer	0.000263	0.00113	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000261	0.00112	CbGpPWpGaD
Midazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.00026	0.00112	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—UROD—head and neck cancer	0.000258	0.00111	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—MAPK3—head and neck cancer	0.000256	0.0011	CbGpPWpGaD
Midazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000256	0.0011	CbGpPWpGaD
Midazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000256	0.0011	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—UROD—head and neck cancer	0.000252	0.00108	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—UROD—head and neck cancer	0.000252	0.00108	CbGpPWpGaD
Midazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000252	0.00108	CbGpPWpGaD
Midazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000251	0.00108	CbGpPWpGaD
Midazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000251	0.00108	CbGpPWpGaD
Midazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.00025	0.00107	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—YAP1—head and neck cancer	0.000249	0.00107	CbGpPWpGaD
Midazolam—CYP2E1—head—head and neck cancer	0.000249	0.00754	CbGeAlD
Midazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000245	0.00105	CbGpPWpGaD
Midazolam—GABRR1—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000245	0.00105	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—MAPK1—head and neck cancer	0.000244	0.00105	CbGpPWpGaD
Midazolam—GABRG3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000239	0.00103	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—TYMS—head and neck cancer	0.000239	0.00103	CbGpPWpGaD
Midazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000238	0.00102	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—GSTM1—head and neck cancer	0.000236	0.00102	CbGpPWpGaD
Midazolam—GABRB1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000236	0.00101	CbGpPWpGaD
Midazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000235	0.00101	CbGpPWpGaD
Midazolam—GABRR1—Neuronal System—MAPK1—head and neck cancer	0.000233	0.001	CbGpPWpGaD
Midazolam—GABRR2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000233	0.001	CbGpPWpGaD
Midazolam—GABRQ—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000233	0.001	CbGpPWpGaD
Midazolam—ABCB1—epithelium—head and neck cancer	0.000228	0.00692	CbGeAlD
Midazolam—CYP4B1—Metabolism—GPX1—head and neck cancer	0.000226	0.000973	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—CYP1A1—head and neck cancer	0.000224	0.000963	CbGpPWpGaD
Midazolam—GABRA6—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000223	0.000958	CbGpPWpGaD
Midazolam—GABRQ—Neuronal System—MAPK1—head and neck cancer	0.000223	0.000957	CbGpPWpGaD
Midazolam—GABRR2—Neuronal System—MAPK1—head and neck cancer	0.000223	0.000957	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—IL2—head and neck cancer	0.000222	0.000954	CbGpPWpGaD
Midazolam—GABRA4—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.00022	0.000946	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000218	0.000938	CbGpPWpGaD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.000218	0.000936	CbGpPWpGaD
Midazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000215	0.000924	CbGpPWpGaD
Midazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000214	0.00092	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000213	0.000916	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000212	0.000911	CbGpPWpGaD
Midazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000209	0.000898	CbGpPWpGaD
Midazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000205	0.000882	CbGpPWpGaD
Midazolam—ABCB1—trachea—head and neck cancer	0.000202	0.00612	CbGeAlD
Midazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000202	0.000866	CbGpPWpGaD
Midazolam—GABRB2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000201	0.000865	CbGpPWpGaD
Midazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.0002	0.000861	CbGpPWpGaD
Midazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000197	0.000845	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—HRAS—head and neck cancer	0.000196	0.000842	CbGpPWpGaD
Midazolam—GABRA5—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000196	0.000841	CbGpPWpGaD
Midazolam—GABRA3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000192	0.000826	CbGpPWpGaD
Midazolam—GABRG3—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000192	0.000825	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—UROD—head and neck cancer	0.00019	0.000817	CbGpPWpGaD
Midazolam—GABRB1—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000189	0.000813	CbGpPWpGaD
Midazolam—GABRA2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000189	0.000811	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	0.000189	0.000811	CbGpPWpGaD
Midazolam—GABRB3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000188	0.000806	CbGpPWpGaD
Midazolam—GABRR1—Neuronal System—HRAS—head and neck cancer	0.000187	0.000805	CbGpPWpGaD
Midazolam—GABRG2—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000184	0.000792	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000184	0.000792	CbGpPWpGaD
Midazolam—GABRG3—Neuronal System—MAPK1—head and neck cancer	0.000183	0.000788	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—MAPK1—head and neck cancer	0.000181	0.000776	CbGpPWpGaD
Midazolam—GABRA6—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000179	0.000769	CbGpPWpGaD
Midazolam—GABRR2—Neuronal System—HRAS—head and neck cancer	0.000179	0.000768	CbGpPWpGaD
Midazolam—GABRQ—Neuronal System—HRAS—head and neck cancer	0.000179	0.000768	CbGpPWpGaD
Midazolam—GABRA4—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000177	0.00076	CbGpPWpGaD
Midazolam—ABCB1—lymphoid tissue—head and neck cancer	0.000176	0.00533	CbGeAlD
Midazolam—GABRB3—BDNF signaling pathway—AKT1—head and neck cancer	0.000173	0.000743	CbGpPWpGaD
Midazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000172	0.000739	CbGpPWpGaD
Midazolam—GABRA6—Neuronal System—MAPK1—head and neck cancer	0.000171	0.000734	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—MAPK1—head and neck cancer	0.000169	0.000725	CbGpPWpGaD
Midazolam—GABRB2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000162	0.000695	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000161	0.000692	CbGpPWpGaD
Midazolam—ABCB1—thyroid gland—head and neck cancer	0.00016	0.00484	CbGeAlD
Midazolam—GABRA5—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000157	0.000675	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—MAPK1—head and neck cancer	0.000154	0.000663	CbGpPWpGaD
Midazolam—GABRA3—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000154	0.000663	CbGpPWpGaD
Midazolam—GABRA2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000152	0.000651	CbGpPWpGaD
Midazolam—GABRB3—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000151	0.000647	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—MAPK1—head and neck cancer	0.00015	0.000644	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—TYMS—head and neck cancer	0.00015	0.000643	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GSTM1—head and neck cancer	0.000148	0.000636	CbGpPWpGaD
Midazolam—GABRG2—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000148	0.000635	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—MAPK1—head and neck cancer	0.000147	0.000633	CbGpPWpGaD
Midazolam—GABRG3—Neuronal System—HRAS—head and neck cancer	0.000147	0.000632	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—HRAS—head and neck cancer	0.000145	0.000623	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000145	0.000623	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—NAT2—head and neck cancer	0.000145	0.000622	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—MAPK1—head and neck cancer	0.000145	0.000622	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—MAPK1—head and neck cancer	0.000144	0.000618	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GPX1—head and neck cancer	0.000142	0.000609	CbGpPWpGaD
Midazolam—ABCB1—head—head and neck cancer	0.000142	0.0043	CbGeAlD
Midazolam—GABRG2—Neuronal System—MAPK1—head and neck cancer	0.000141	0.000606	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.00014	0.000603	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CYP1A1—head and neck cancer	0.00014	0.000603	CbGpPWpGaD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	0.000139	0.000597	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000139	0.000595	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000138	0.000592	CbGpPWpGaD
Midazolam—GABRA6—Neuronal System—HRAS—head and neck cancer	0.000137	0.000589	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—HRAS—head and neck cancer	0.000135	0.000582	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—NAT2—head and neck cancer	0.000135	0.000579	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PTGS2—head and neck cancer	0.000133	0.000573	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000133	0.000572	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000131	0.000564	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000129	0.000555	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—DPYD—head and neck cancer	0.000127	0.000545	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000124	0.000535	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—HRAS—head and neck cancer	0.000124	0.000532	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—MAPK1—head and neck cancer	0.000123	0.00053	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—YAP1—head and neck cancer	0.00012	0.000517	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—HRAS—head and neck cancer	0.00012	0.000517	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—HRAS—head and neck cancer	0.000118	0.000508	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000118	0.000508	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—DPYD—head and neck cancer	0.000118	0.000507	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—UROD—head and neck cancer	0.000117	0.000503	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PTEN—head and neck cancer	0.000116	0.0005	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—HRAS—head and neck cancer	0.000116	0.000499	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—HRAS—head and neck cancer	0.000115	0.000496	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—HRAS—head and neck cancer	0.000113	0.000487	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—YAP1—head and neck cancer	0.000112	0.000481	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000111	0.000475	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—NAT2—head and neck cancer	0.000107	0.00046	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000107	0.000459	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—MAPK1—head and neck cancer	0.000106	0.000454	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—NAT2—head and neck cancer	0.000105	0.00045	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—NAT2—head and neck cancer	0.000105	0.000449	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000103	0.000443	CbGpPWpGaD
Midazolam—ABCB1—lymph node—head and neck cancer	9.92e-05	0.00301	CbGeAlD
Midazolam—GABRA1—Neuronal System—HRAS—head and neck cancer	9.9e-05	0.000426	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—DPYD—head and neck cancer	9.38e-05	0.000403	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	9.31e-05	0.0004	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—DPYD—head and neck cancer	9.19e-05	0.000395	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—DPYD—head and neck cancer	9.17e-05	0.000394	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—YAP1—head and neck cancer	8.9e-05	0.000383	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	8.81e-05	0.000378	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—YAP1—head and neck cancer	8.72e-05	0.000375	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—YAP1—head and neck cancer	8.7e-05	0.000374	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—HRAS—head and neck cancer	8.47e-05	0.000364	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	8.38e-05	0.00036	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	8.38e-05	0.00036	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PTGS2—head and neck cancer	8.34e-05	0.000358	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PIK3CA—head and neck cancer	8.2e-05	0.000352	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NAT2—head and neck cancer	7.89e-05	0.000339	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PTEN—head and neck cancer	7.27e-05	0.000313	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	7.27e-05	0.000312	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—TYMS—head and neck cancer	7.23e-05	0.000311	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTM1—head and neck cancer	7.15e-05	0.000307	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	7.03e-05	0.000302	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—DPYD—head and neck cancer	6.92e-05	0.000297	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GPX1—head and neck cancer	6.84e-05	0.000294	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP1A1—head and neck cancer	6.77e-05	0.000291	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—TYMS—head and neck cancer	6.73e-05	0.000289	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—AKT1—head and neck cancer	6.7e-05	0.000288	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTM1—head and neck cancer	6.65e-05	0.000286	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—YAP1—head and neck cancer	6.57e-05	0.000282	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GPX1—head and neck cancer	6.37e-05	0.000274	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP1A1—head and neck cancer	6.3e-05	0.000271	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	5.94e-05	0.000255	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—TYMS—head and neck cancer	5.35e-05	0.00023	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTM1—head and neck cancer	5.29e-05	0.000227	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—TYMS—head and neck cancer	5.24e-05	0.000225	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—TYMS—head and neck cancer	5.23e-05	0.000225	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTM1—head and neck cancer	5.18e-05	0.000222	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTM1—head and neck cancer	5.17e-05	0.000222	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CA—head and neck cancer	5.13e-05	0.000221	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GPX1—head and neck cancer	5.06e-05	0.000217	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP1A1—head and neck cancer	5.01e-05	0.000215	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GPX1—head and neck cancer	4.96e-05	0.000213	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GPX1—head and neck cancer	4.95e-05	0.000213	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP1A1—head and neck cancer	4.91e-05	0.000211	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP1A1—head and neck cancer	4.9e-05	0.00021	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NAT2—head and neck cancer	4.86e-05	0.000209	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—DPYD—head and neck cancer	4.26e-05	0.000183	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—AKT1—head and neck cancer	4.19e-05	0.00018	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—YAP1—head and neck cancer	4.05e-05	0.000174	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PTGS2—head and neck cancer	4.03e-05	0.000173	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—TYMS—head and neck cancer	3.94e-05	0.000169	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTM1—head and neck cancer	3.9e-05	0.000168	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PTGS2—head and neck cancer	3.75e-05	0.000161	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GPX1—head and neck cancer	3.73e-05	0.00016	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP1A1—head and neck cancer	3.7e-05	0.000159	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PTEN—head and neck cancer	3.51e-05	0.000151	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PTEN—head and neck cancer	3.27e-05	0.000141	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PTGS2—head and neck cancer	2.98e-05	0.000128	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PTGS2—head and neck cancer	2.92e-05	0.000125	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PTGS2—head and neck cancer	2.91e-05	0.000125	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PTEN—head and neck cancer	2.6e-05	0.000112	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PTEN—head and neck cancer	2.55e-05	0.000109	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PTEN—head and neck cancer	2.54e-05	0.000109	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CA—head and neck cancer	2.48e-05	0.000107	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—TYMS—head and neck cancer	2.43e-05	0.000104	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.4e-05	0.000103	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CA—head and neck cancer	2.31e-05	9.91e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GPX1—head and neck cancer	2.3e-05	9.88e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.28e-05	9.78e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTGS2—head and neck cancer	2.2e-05	9.44e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—AKT1—head and neck cancer	2.02e-05	8.7e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTEN—head and neck cancer	1.92e-05	8.24e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—AKT1—head and neck cancer	1.88e-05	8.1e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CA—head and neck cancer	1.83e-05	7.88e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CA—head and neck cancer	1.8e-05	7.72e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CA—head and neck cancer	1.79e-05	7.7e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—AKT1—head and neck cancer	1.5e-05	6.44e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—AKT1—head and neck cancer	1.47e-05	6.3e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—AKT1—head and neck cancer	1.46e-05	6.29e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.35e-05	5.82e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.35e-05	5.81e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTEN—head and neck cancer	1.18e-05	5.07e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—AKT1—head and neck cancer	1.1e-05	4.75e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CA—head and neck cancer	8.33e-06	3.58e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—AKT1—head and neck cancer	6.8e-06	2.92e-05	CbGpPWpGaD
